Mannheim

• B-NHL 2013 - Treatment protocol of the NHL-BFM and the NOPHO study groups for mature aggressive B-cell lymphoma and leukemia in children and … Ended recruitment
  2023-505509-18-00 5 2017-07-12 mature aggressive B-cell lymphoma and leukemia in children and adolesc
• Further 2 years of adjuvant imatinib may improve recurrence-free survival (RFS) of patients who are at a high risk of GIST recurrence despit … Ended recruitment
  2024-512243-23-00 5 2014-11-07 gastrointestinal stromal tumor
• Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended recruitment
  2024-511096-15-00 5 2014-08-01 Breast Cancer
• A prospective, multicentre, randomised, double-dummy, double-blind, placebo-controlled 3-way Phase III study to investigate the efficacy and … Halted
  2022-502903-31-00 5 2025-11-05 Patients with ADHD (according to ICD-10 / DSM-5)
• CATALINA-2: A Phase 2 Study of TORL-1-23 in Advanced Ovarian Cancer Halted
  2024-517190-24-00 4 2025-09-16 Peritoneal Cancer
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Study, to Assess Efficacy, Safety and Immunogenicity of JNJ-6404 … Halted
  2023-505096-68-00 4 2025-01-14 Preclinical Alzheimer’s Disease
• Enhancing recovery in early schizophrenia: A study comparing cannabidiol and placebo as add-on to standard antipsychotic treatment. Halted
  2024-517198-26-00 4 2017-02-17 Remitted early phase schizophrenia
• "A study in healthy people to test how 2 different formulations of a combination treatment (vicadrostat and empagliflozin) are taken up in … Ended
  2025-521650-42-00 3 2025-09-04 Healthy volunteer trial
• A study in healthy men to test whether carbamazepine influences the amount of nerandomilast in the blood Ended
  2025-521279-30-00 3 2025-08-06 Healthy volunteer trial
• Axicabtagene Ciloleucel CAR T-Cells in Patients with relapsed or refractory primary mediastinal B-Cell Lymphoma Ended
  2024-510972-19-00 4 2025-03-13 Primary mediastinal large B-cell lymphoma (PMBCL)
• Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults with Type 2 Diabetes M … Ended
  2024-512562-34-00 4 2025-02-24 Type 2 Diabetes Mellitus
• An Open-Label, Multicentre Phase 1b/2a Clinical Trial of BI-1607, an Fc-Engineered Monoclonal Antibody to FcγRIIB (CD32b), in Combination wi … Ended
  2024-512670-10-00 9 2025-02-13 Unresectable or Metastatic Melanoma
• With Ponatinib on the track for treatment-free-remission in chronic myeloid leukemia Ended
  2024-518971-76-00 4 2024-12-21 chronic myeloid leukemia in chronic phase
• Effects of AZD5004 in adults who are living with obesity or overweight with at least 1 weight-related medical condition Ended
  2024-513691-18-00 4 2024-12-11 Participants living with Obesity or Overweight with at least 1 comorbi
• Adjuvant chemotherapy with gemcitabine and cisplatin compared to standard of care after curative intent resection of cholangiocarcinoma and … Ended
  2024-517340-61-00 5 2024-11-19 Patients after curative intent resection of cholangiocarcinoma (intrah
• CK-0045 proof-of-concept study Ended
  2024-514191-41-00 4 2024-09-16 Type 2 diabetes and Obesity
• A Phase 2 Parallel Group Study in Adults with Type 2 Diabetes to evaluate Efficacy and Safety of GL0034 Ended
  2024-513279-41-00 4 2024-09-06 Type 2 diabetes mellitus
• CABONEN – a phase II trial of Cabozantinib in patients with advanced, low proliferative NEN G3 Ended
  2024-510863-50-00 4 2024-08-30 Neuroendocrine Neoplasia Neuroendocrine Tumor
• A study to learn about the safety of BAY 3283142 in people with mild to moderate high blood pressure Ended
  2024-512060-58-00 3 2024-08-07 Chronic kidney disease
• A randomized, single-center, double-blind, placebo-controlled, first-in-human trial with single and multiple ascending doses to determine sa … Ended
  2024-512510-17-00 1 2024-08-05 Treatment of pain
• A study to learn about the taste of Vericiguat given in liquid form in healthy male participants aged 18 to 45 years Ended
  2023-508447-52-00 3 2024-06-28 Heart failure in children
• A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended
  2024-511076-32-00 6 2024-06-21 Hypercholesterolemia
• A study in healthy people to compare how 2 different low dose formulations of BI 1015550 are taken up in the body Ended
  2023-509951-15-00 2 2024-06-06 Pharmacokinetic trial
• A study to test how BI 456906 is taken up in the blood of people with and without kidney problems Ended
  2023-508557-13-00 3 2024-05-08 Renal impairment (mild, moderate and severe)

Showing 265–288 of 355 trials